“There are likely genetic factors that affect an individual’s ability to lose weight,” said the doctor, who was not involved in the study. “Simply stated, despite similar efforts, caloric restriction ...

Gut‑hormone incretins (e.g., GLP‑1 agonists) are the fastest growing segment, forecast to expand at a 33.15% CAGR through ...

Levita Magnetics announced today that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic ...

New clearance expands clinical use of the disruptive Dynamic Magnetic Positioning™ technology for liver retraction in bariatric and hiatal hernia ...

A new study reveals that bariatric surgery results in significantly greater weight loss compared to popular GLP-1 drugs.